Insurance-routed · Provider review
Found review: the only program here that works with insurance instead of around it
Every other GLP-1 platform we cover is built on the assumption that insurance will say no, and prices itself accordingly. Found’s Medicare Bridge does the opposite — it runs branded Zepbound, Wegovy or Foundayo through your existing Part D plan at an advertised $50 copay, and files the paperwork for you.
Published · Rates as published by Found on that date · Editorial score 9.2 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The reason cash-pay compounded GLP-1s exist as an industry is that the branded products cost roughly $650 a month without coverage and prior authorisation for weight loss is refused often enough to be treated as a dead end. Nearly every platform in this vertical is a response to that: no insurance, no paperwork, a compounded preparation and a low monthly rate.
Found built the other thing. For adults aged 65 to 75 with Part D drug coverage, the Bridge verifies the plan, files and tracks the prior authorisation, and puts branded medication on a $50 copay. Add membership from $49 a month on annual billing and the advertised total is $99 — $1,188 across a year.
The short answer
- Against cash
- $6,612 a year cheaper. $1,188 against roughly $7,800 for the same branded medication bought without coverage.
- Against compounded
- $360 a year more. The cheapest compounded semaglutide we rank is $828 a year. The Bridge buys an FDA-approved branded product for about $360 more.
- The catch
- Almost nobody qualifies. Ages 65 to 75, with Medicare Part D, and a clinical indication that survives prior authorisation. Outside that window, Found will not quote you a price at all.
Three ways to buy the same class of drug
The table sets the Bridge against the two routes it sits between. The right-hand column is the one that usually gets lost in a price comparison: what you are actually receiving, since a compounded preparation and an FDA-approved branded product are not the same purchase at any price.
| Route | Per month | Per year | What you receive |
|---|---|---|---|
| Found Medicare Bridge | $99 | $1,188 | Branded Zepbound, Wegovy or Foundayo through Part D |
| Cheapest compounded program | $69 | $828 | Compounded semaglutide, not an FDA-approved finished product |
| Branded, paid in cash | ~$650 | ~$7,800 | The same branded medication with no coverage applied |
Read the first two rows together and the result is genuinely unusual: for roughly $30 a month more than the cheapest compounded program in this vertical, an eligible patient gets the branded, FDA-approved medication instead. Every other review on this site has to weigh compounded status against price. For this narrow group, the trade largely disappears.
Why a bridge is needed in the first place
Medicare Part D is barred by statute from covering drugs used for weight reduction. That exclusion is still in force, which is why a program has to exist to work around it and why the name is more candid than most marketing. Coverage therefore depends on the clinical indication documented in the prior authorisation, not on wanting to lose weight.
That documentation is the actual product. A prior authorisation is a formatting exercise as much as a clinical one — the plan wants a qualifying diagnosis, a rationale and often a treatment history, submitted the way that plan expects. Found says its team files and tracks it end to end and verifies your plan before you pay. For someone quoted $650 at a pharmacy counter and told to take it up with their insurer, outsourcing that is the whole value. Medicare’s own guide to Part D drug coverage is worth reading alongside Found’s eligibility check, because formulary tier and coverage phase are what determine your actual copay.
$50 is a starting copay, not a guaranteed rate. Part D plans differ in formulary tier and deductible, and out-of-pocket cost can move across the plan year as you pass through coverage phases. Confirm your specific copay with Found before the first shipment rather than budgeting from the advertised figure.
The price Found will not publish
Outside the Bridge, Found sells an ordinary telehealth weight program — biology-first, medically supervised, clinician oversight included, cancel anytime — and does not publish what it costs. The pricing is described as affordable monthly plans personalised to your protocol, which is a description rather than a number.
That is a genuine mark against it. In a vertical where TrimRx publishes $149 and JoinFridays publishes a four-rung ladder, requiring an intake before quoting a price puts the burden of comparison on the patient. An unknowable price is a finding about a provider, not a gap to be filled with an estimate — and it is the reason this review is built around the one program Found does price.
What the membership buys
The $49 is not just an access fee. It covers board-certified clinician review within one to two days, monthly check-ins, in-app side-effect support and messaging, alongside the insurance administration. Found reports 300,000-plus members and about 12% average body weight loss at one year across 1,773 tracked users — a stated cohort and time frame, which is more disclosure than most platforms in this category offer, even if it remains company-reported rather than trial data.
The care matters more than usual here. The National Institute of Diabetes and Digestive and Kidney Diseases notes these medications work best alongside a lifestyle program and that regain is likely after stopping without sustained change — and for a patient in their late sixties or seventies, monthly clinical contact is a substantive part of what is being bought rather than a bundled extra.
What Found does well
- Branded FDA-approved medication at an advertised $50 copay
- Files and tracks the Part D prior authorisation on your behalf
- Verifies coverage before you pay anything; eligibility check is free
- Board-certified clinician review within one to two days
- Monthly check-ins, in-app side-effect support and messaging included
- Reports a cohort size and time frame alongside its results figure
- About $6,612 a year cheaper than buying the same drugs in cash
Where it falls short
- The Bridge is limited to adults aged 65 to 75 with Medicare Part D
- $50 is a starting copay that varies by plan, tier and coverage phase
- The $49 membership rate requires annual billing
- Coverage still depends on a prior authorisation that can be refused
- The non-Medicare program publishes no price at all
- Part D remains statutorily barred from covering weight-reduction drugs
How the program runs
- Run the free eligibility check — about three minutes, no commitment
- Found verifies your Part D plan and confirms coverage before you pay
- A board-certified clinician reviews your case, typically within one to two days
- Found files and tracks the prior authorisation with your plan
- Medication is dispensed by a licensed pharmacy and shipped to your door
- Monthly clinician check-ins and in-app support continue through the program
Who it suits
Adults aged 65 to 75 with Part D coverage, and essentially nobody else. Within that group the case is close to overwhelming: branded medication, clinical supervision and the insurance paperwork handled, for roughly $30 a month more than the cheapest compounded program on the market. If you are in the window, run the free check before considering anything else on this site.
Outside it, Found is hard to evaluate, because the alternative program does not carry a price. Anyone under 65 or without Part D is better served comparing published rates — Embody at $69, TrimRx at $149 with a price lock, or the wider field on the oral GLP-1 rankings.
The verdict
The Medicare Bridge is the most economically interesting thing in this vertical. Every other provider we cover competes on how cheaply it can sell a compounded preparation to someone insurance has turned away. Found competes on getting the insurer to pay for the real drug, and where that works the arithmetic is not close — $1,188 a year against roughly $7,800.
The qualifications are severe and honestly stated. A ten-year age window, a specific coverage type, a copay that can move with your plan year, and a statutory exclusion that means approval is never automatic. Found does not pretend otherwise, and the free upfront check is the right way to handle it.
Strongly recommended if you are 65 to 75 with Part D — start with the eligibility check, and confirm your actual copay and the membership billing term before the first shipment. If you fall outside that window, press for a published price before enrolling in anything.
Found: common questions
What is the Found Medicare GLP-1 Bridge?
A program for adults aged 65 to 75 with Medicare Part D drug coverage. Instead of selling a cash-pay compounded GLP-1, Found runs branded medication through your existing Part D plan — verifying your coverage, then filing and tracking the prior authorisation. Covered options are Zepbound, Wegovy or Foundayo.
What does the Bridge cost?
Found advertises a total starting at $99 a month: a $50 medication copay plus membership from $49 a month when billed annually. That is $1,188 across a year. Found states coverage and copays vary by eligibility and insurance approval, so $50 is a starting copay rather than a fixed rate.
How does that compare with paying cash for the same drugs?
Branded Zepbound or Wegovy bought in cash runs around $650 a month — roughly $7,800 a year. At $99 a month the Bridge is about $6,612 a year cheaper for the same branded medication. That is the largest arithmetic gap in this vertical, and it exists entirely because the medication is going through insurance rather than around it.
How does it compare with a cheap compounded program?
This is the more striking comparison. The cheapest compounded semaglutide we rank is $69 a month, or $828 a year. The Bridge is $1,188 — about $360 more across a year, for an FDA-approved branded product rather than a compounded preparation. If you qualify, that is a small premium for a materially different regulatory status.
Why does a "bridge" need to exist at all?
Because Medicare Part D is barred by statute from covering drugs used for weight reduction. That exclusion has not been repealed, which is precisely why coverage depends on the clinical indication documented in the prior authorisation. The programme name is honest about what it is doing.
What is the $49 membership for?
Found's ongoing care: board-certified clinician review, monthly check-ins, in-app side-effect support and messaging, plus the administrative work of verifying your plan and filing the prior authorisation. Note that the $49 rate depends on annual billing, so the cheapest advertised price does involve a twelve-month term.
What does the non-Medicare Found program cost?
Found does not publish a rate for it — the pricing is described as affordable monthly plans personalised to your protocol. That is a real gap. Every flat-rate competitor in this vertical publishes a number before intake, and an unpublished price is a finding about a provider rather than a detail to fill in later.
Is the eligibility check free?
Yes. Found states the check takes about three minutes, carries no commitment, and that coverage is verified before you pay anything. Given that eligibility is the entire question for this program, a free check ahead of payment is the right structure.
What results does Found report?
About 12% average body weight loss at one year across 1,773 tracked users, alongside 300,000-plus members and a 4.89 average rating. A stated cohort size and time frame is more than most platforms disclose, though it is still company-reported data rather than a trial.
Keep comparing
See how the rest of the market prices the same treatment on the oral glp-1 rankings.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what Found published on the date above and changes frequently. The $50 copay is a starting figure that varies by eligibility, plan formulary and coverage phase, and the $49 membership rate depends on annual billing. The cash branded comparison is an approximate market rate, not a Found quote, and the compounded comparison is the lowest published rate in our rankings on the same date.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Found, and does not sell treatment. Read our ranking methodology.